Disease: Hereditary amyloidosis
- 2023 FDA TIDES (Peptides and Oligonucleotides) Harvest
- 2024 Australia-New Zealand Expert Consensus Statement on Cardiac Amyloidosis
- 2024 Update on Classification, Etiology, and Typing of Renal Amyloidosis
- A Novel Approach to Cardiac Magnetic Resonance Scar Characterization in Patients Affected by Cardiac Amyloidosis: A Pilot Study
- Acoramidis in Transthyretin Amyloid Cardiomyopathy
- Acoramidis in Transthyretin Amyloid Cardiomyopathy. Reply
- Advances in the diagnosis and treatment of transthyretin amyloid cardiomyopathy
- Altered gut microbiota in Taiwanese A97S predominant transthyretin amyloidosis with polyneuropathy
- Amyloid myopathy: expanding the clinical spectrum of transthyretin amyloidosis-case report and literature review
- Amyloid Typing in Cardiac Amyloidosis Using Western Blotting
- Amyloïdose héréditaire à transthyrétine accompagnée d’un syndrome du canal carpien
- Apolipoprotein C-III amyloidosis in white lions (<em>Panthera leo</em>)
- Apolipoprotein C-III amyloidosis in white lions (Panthera leo)
- Assessment of potential transthyretin amyloid cardiomyopathy cases in the Brazilian public health system using a machine learning model
- ATTR Gene Variants in HCM
- Autosomal dominant chronic tubulointerstitial nephropathy: do not forget amyloidosis
- Axonal excitability as an early biomarker of nerve involvement in hereditary transthyretin amyloidosis
- bDMARD can prevent the progression of AA amyloidosis to end-stage renal disease
- Biophysical insight into anti-amyloidogenic nature of novel ionic Co(II)(phen)(H<sub>2</sub>O)<sub>4</sub>]<sup>+</sup>[glycinate]<sup>-</sup> chemotherapeutic drug candidate against human lysozyme aggregati
- Bullous Amyloidosis as a cutaneous feature of Familial Lysozyme Amyloidosis
- Canakinumab treatment real world evidence in 3 monogenic periodic fever syndromes in 2009-2022: an interim analysis using the French JIR cohort database
- Cardiac amyloid deposition and the forensic autopsy - A review and analysis
- Cardiac amyloidosis in Latin America: Gaps and opportunities to increase awareness of the disease. Findings from the AMILO-LATAM research group
- Cardiac DPD-uptake time dependency in ATTR patients verified by quantitative SPECT/CT and semiquantitative planar parameters
- Cardiopulmonary Exercise Testing in Evaluating Transthyretin Amyloidosis
- Characterization of heterozygous ATTR Tyr114Cys amyloidosis-specific induced pluripotent stem cells
- Characterization of Transthyretin Mutation G47V Associated with Hereditary Cardiac Amyloidosis
- Circulating transthyretin and retinol binding protein 4 levels among middle-age V122I <em>TTR</em> carriers in the general population
- Clinical and Prognostic Implications of Right Ventricular Uptake on Bone Scintigraphy in Transthyretin Amyloid Cardiomyopathy
- Clinical spectrum of Transthyretin amyloidogenic mutations among diverse population origins
- Cost-effectiveness of transthyretin cardiac amyloidosis screening and treatment: A Dilemma for the clinician
- Deep learning approach for automated segmentation of myocardium using bone scintigraphy single-photon emission computed tomography/computed tomography in patients with suspected cardiac amyloidosis
- Detection of TTR Amyloid in the Conjunctiva Using a Novel Fluorescent Ocular Tracer
- Dynamic Reconstruction Using Bilateral Lengthening Temporalis Myoplasty for Facial Palsies in Patients with Hereditary Skin Laxity
- Early diagnosis in ATTRv amyloidosis, how early is enough? How early is possible?
- Echocardiographic tools for prognostic stratification in transthyretin cardiac amyloidosis: a new arrow in the quiver
- Efficacy of topical gabapentin in women with primary macular amyloidosis: A side-by-side triple-blinded randomized clinical trial
- Eplontersen: First Approval
- Exploring clinical variability in gelsolin amyloidosis: Brazilian family case study with confocal microscopy
- False Negative (99m)Tc-DPD Scintigraphy in pVal50Met (Val30Met) Hereditary Transthyretin Amyloidosis
- Familial mediterranean fever
- Frequency of misdiagnosis in hypertrophic cardiomyopathy
- Gastric, Colonic, and Rectal Amyloidosis in the Setting of Familial Mediterranean Fever: A Unique Cause of Intractable Diarrhea
- Hereditary Transthyretin Amyloidosis and the Impact of Classic and New Treatments on Kidney Function: A Review
- Hereditary transthyretin amyloidosis presenting with carpal tunnel syndrome
- Hereditary Transthyretin Amyloidosis: Impact of Classic and New Treatments on Kidney Function
- Heterogeneity in families with ATTRV30M amyloidosis: a historical and longitudinal Portuguese case study impact for genetic counselling
- High-Sensitivity Cardiac Troponin T to Exclude Cardiac Involvement in TTR Variant Carriers and ATTRv Amyloidosis Patients
- Histological Typing in Patients With Cardiac Amyloidosis: JACC Review Topic of the Week
- Historic characteristics and mortality of patients in the Swiss Amyloidosis Registry
- Iatrogenic Amyloid Polyneuropathy Following Domino Liver Transplantation: A Case Report
- Impact of Baseline Neuropathy Severity on Vutrisiran Treatment Response in the Phase 3 HELIOS-A Study
- Impact of vutrisiran on exploratory cardiac parameters in hereditary transthyretin-mediated amyloidosis with polyneuropathy
- In adults with ATTR cardiac amyloidosis, patisiran reduced decline in functional capacity at 12 mo
- Incidence and causes of hospitalization in patients with transthyretin (ATTR-CA) and light chain (AL-CA) cardiac amyloidosis
- Inhibitors of Transthyretin Amyloidosis: How to Rank Drug Candidates Using X-ray Crystallography Data
- Late-onset familial amyloidosis polyneuropathy associated with c.186G>C in transthyretin
- Letter to the editor concerning "Cardiac [99mTc]Tc-hydroxydiphosphonate uptake on bone scintigraphy in patients with hereditary transthyretin amyloidosis: an early follow-up marker?"
- Long-term treatment of hereditary transthyretin amyloidosis with patisiran: multicentre, real-world experience in Italy
- Longitudinal analysis of serum neurofilament light chain levels as marker for neuronal damage in hereditary transthyretin amyloidosis
- Macular amyloidosis diagnostic outcomes of skin biopsy: A systematic review
- Modern Perspectives on Peripheral Neuropathology
- Multiorgan Dysfunction and Associated Prognosis in Transthyretin Cardiac Amyloidosis
- Nanoparticles and siRNA: A new era in therapeutics?
- Neurofilament Light Chains in Systemic Amyloidosis: A Systematic Review
- Neuropsychiatric symptoms with focus on apathy and irritability in sporadic and hereditary cerebral amyloid angiopathy
- Non-Cardiac Amyloidosis Findings Are Not Increased in African American Carriers of TTR V142I with Heart Failure and/or Arrhythmia
- Novel electrocardiographic criteria may render possible the more accurate recognition of cardiac amyloidosis
- OCT angiography indices and the choroidal vascularity index in wild-type transthyretin (TTR) amyloidosis (ATTRwt)
- Origin of Transthyretin in Cerebral Amyloid Angiopathy
- Outcomes of Octogenarian Patients Treated with Tafamidis for Transthyretin Amyloid Cardiomyopathy
- Pan-Immune-Inflammation Value Could Be a New Marker to Predict Amyloidosis and Disease Severity in Familial Mediterranean Fever
- Patisiran exposure in early pregnancy: a case report
- Patisiran, an RNAi therapeutic for hereditary transthyretin-mediated amyloidosis: Sub-analysis in Taiwanese patients from the APOLLO study
- Performance of (99m)Tc-PYP scintigraphy in the diagnosis of hereditary transthyretin cardiac amyloidosis
- Performance of <sup>99m</sup>Tc-PYP scintigraphy in the diagnosis of hereditary transthyretin cardiac amyloidosis
- Physical fitness in adolescent patients with familial Mediterranean fever
- Predicting genetic risk factors for AA amyloidosis in Algerian patients with familial Mediterranean fever
- Prevalence of moderate-severe aortic stenosis in patients with cardiac amyloidosis in a referral center
- Prognostic Value of Standard Heart Failure Medication in Patients with Cardiac Transthyretin Amyloidosis
- Quantitative muscle ultrasound as a disease biomarker in hereditary transthyretin amyloidosis with polyneuropathy
- Rare ATTR wild-type cardiac amyloidosis after kidney transplantation
- Rare c.302C>T TTR Variant Associated with Transthyretin Amyloidosis
- Real life experience of tafamidis for the treatment of Spanish patients with Val30Met transthyretin amyloidosis with polyneuropathy
- Real-life experience with inotersen at CEPARM, Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro
- Recurrent Bouts of Fever and Transient Hydrosalpinx Manifested in a Female Carrying MEFV G304R Gene Variant: A Case Report
- RNA therapeutics for metabolic disorders
- Serum neurofilament light chain in hereditary transthyretin amyloidosis: validation in real-life practice
- Simultaneous onset of acute myocardial infarction, bicuspid aortic stenosis, and cardiac transthyretin amyloidosis-A clinically complex confluence
- Structures and Dynamics of β-Rich Oligomers of ATTR (105-115) Assembly
- Temporal Ordering of Biomarkers in Dutch-Type Hereditary Cerebral Amyloid Angiopathy
- Time is a gift: time-dependent uptake of DPD in cardiac amyloidosis
- Tissue mapping by cardiac magnetic resonance imaging for the prognostication of cardiac amyloidosis: A systematic review and meta-analysis
- Tolerability and effectiveness of beta-blockers in patients with cardiac amyloidosis: A systematic review and meta-analysis
- Transthyretin amyloid polyneuropathy in France: A cross-sectional study with 413 patients and real-world tafamidis meglumine use (2009-2019)
- Trypsin-induced aggregation of transthyretin Valine 30 variants associated with hereditary amyloidosis
- Utility of Genetic Testing in Patients with Transthyretin Amyloid Cardiomyopathy: A Brief Review
- Vutrisiran (Amvuttra): CADTH Reimbursement Recommendation: Indication: For the treatment of stage 1 or stage 2 polyneuropathy in adult patients with hereditary transthyretin-mediated amyloidosis
- Vutrisiran: a new drug in the treatment landscape of hereditary transthyretin amyloid polyneuropathy
- Whole genome sequencing increases the diagnostic rate in Charcot-Marie-Tooth disease